Dr. Mark Lovern recently joined Certara (formerly Quantitative Solutions) with 14 years of experience in applying modeling and simulation tools and techniques toward optimally informing drug development decision-making. Mark’s previous work history has been split approximately equally between biopharmaceutical companies (GSK and UCB) and companies that support the biopharmaceutical industry (Quintiles and Pharsight, now Certara). In addition to modeling pharmacokinetic and pharmacodynamic data across a wide variety of compounds and therapeutic areas, Mark has also taught over 50 technical training workshops on modeling tools and methodology. His most recent therapeutic area experience has been with therapies for infectious disease and autoimmune disorders.
Mark was awarded a PhD in Biomathematics form North Carolina State University in 1997. His favorite leisure activities include hosting dinner parties, traveling, reading and enjoying films.